Apparently, the micro-vessel density and VEGFA+ cells were decreased in the R848 group and the RFA+R848 group (Figures 6A, , B, E, F), while RFA+R848 did not further reduce the tumor micro-vessels compared with R848 monotherapy. The gene discussed is VEGFA; the disease is neoplasm.